FDA to Hold Public Meeting of
Antiviral Drugs Advisory Committee
The Food and Drug
Administration (FDA) will hold a public meeting of its Antiviral Drugs
Advisory Committee on October 19 and 20, 2006, to discuss design issues in
the development of products for treatment of chronic hepatitis C,
including co-infection with HIV. Click here
to find out the location and times and other details about this meeting.
Nominations for New Members for the Department of Health and
Human Services (HHS) Panel on Antiretroviral Guidelines for Adults and
Adolescents
The HHS Panel on
Antiretroviral Guidelines for Adults and Adolescents (the Panel) is
accepting nominations for new members with clinical research and/or
practice expertise in HIV management to serve a 3-year term beginning
February 2007, with an option of renewal of membership at the end of the
term.
The Panel, a Working Group
of the Office of AIDS Research Advisory Council (OARAC) of the National
Institutes of Health (NIH), is composed of approximately 30 members who
are clinicians, researchers, academicians, HHS representatives, and
community representatives with expertise in HIV management. The Panel
meets monthly via teleconferencing and annually in a face-to-face meeting
to review and critically evaluate emerging scientific data relating to
antiretroviral therapy. The members actively engage in the preparation and
update of the “Guidelines for the Use of Antiretroviral Agents in
HIV-1-Infected Adults and Adolescents,” which appears as a Living Document
on the http://AIDSinfo.nih.gov Web
site. This document is widely
used by HIV practitioners and researchers in the United States and
worldwide, with an average of more than 5,000 downloads a day.
Panel members are not compensated for their time
commitment and travel support is not provided for participation.
The Panel is currently
seeking nominations for new members with expertise in HIV clinical
trials, outcome research, and/or clinical practice who will work
with other Panel members in critically evaluating new information and
preparing guidelines revisions. The candidates shall be recognized
experts in HIV medicine with outstanding records of publications and
presentations in areas related to antiretroviral therapy. The
successful candidates shall serve a 3-year term beginning February
2007.
The nomination
should include a curriculum vitae and a letter of nomination or letter of
interest outlining what qualities and contributions the candidate may
bring to the Panel. Please
submit nominations no later than September 30, 2006,
to:
Alice Pau, Pharm.D.
Executive Secretary, Division of Clinical Research, NIAID-NIH, Bldg 10, Rm
11C103, Bethesda, MD 20892 or e-mail to apau@niaid.nih.gov.
Community Member Sought for the HHS
Panel on Antiretroviral Guidelines for Adults and
Adolescents
The Panel is also seeking
nominations for a new community representative to serve a 3-year term with
potential for renewal. The Panel welcomes diversified representation in
the community membership reflecting the demographics of the current HIV
epidemic in the United States. The community member may assist the Panel
in identifying and addressing unique treatment aspects that relate to the
constituency he/she represents. The candidate shall have knowledge
and involvement in issues related to HIV infection in adults, as evidenced
by experience in HIV treatment education/advocacy or clinical/public
policy initiatives related to HIV treatment. Interested
candidates should submit their curriculum vitae or a
pertinent biographical sketch and a letter of nomination or letter of
interest outlining the experience and qualifications relevant to
this position and the contributions the candidate is likely to bring to
the Panel.
Please submit nominations to Alice Pau by September
30.
